Skip to content
2000
Volume 32, Issue 13
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Emerging evidence reveals that interactions between the nervous system and tumor biology significantly influence cancer progression, metastasis, and therapeutic outcomes. Here, we elucidate the neurobiological mechanisms that underpin tumor development, highlighting the dynamic role of neural components within the tumor microenvironment (TME). Neural signals and structural adaptations in the TME stimulate tumorigenesis and enable cancer cell plasticity, mimicking neurodevelopmental processes. Astrocytic glial cells release neurotrophic factors that support metastatic colonization and enhance tumor cell survival. Notably, cancer cells can establish pseudo-tripartite synapses with neurons, promoting both proliferation and invasion. We explore the cancer-neural network interplay, emphasizing how axonal remodeling, circuit reorganization, and synaptic dysfunction not only drive tumor growth but also contribute to associated symptoms like seizures and chronic pain. Molecularly, mutations such as in and abnormalities in neurotransmitter signaling reveal how neurotumors communicate and adapt. Furthermore, metabolic stress responses from tumor cells can activate nociceptive neurons, sustaining malignant progression. Understanding these neurobiological interactions opens avenues for novel therapeutic strategies. Precision neuro-oncology may benefit from targeting neurotrophic signaling, synaptic pathways, and neuronal differentiation programs. Advances in biomarker research from neurotumors also contribute to improved diagnostic and prognostic tools. By integrating neuroscience insights into oncological frameworks, we propose a paradigm shift toward therapies that intercept the neural circuitry sustaining malignancies. This neuro-oncological approach holds promise in addressing aggressive cancer phenotypes and improving patient outcomes.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128402718250806151308
2025-08-13
2026-03-01

  • From This Site

    /content/journals/cpd/10.2174/0113816128402718250806151308
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. WinklerF. VenkateshH.S. AmitM. Cancer neuroscience: State of the field, emerging directions.Cell202318681689170710.1016/j.cell.2023.02.002 37059069
     [Google Scholar]
  2. ZhangZ. LeiA. XuL. Similarity in gene-regulatory networks suggests that cancer cells share characteristics of embryonic neural cells.J. Biol. Chem.201729231128421285910.1074/jbc.M117.785865 28634230
     [Google Scholar]
  3. HussainM.S. MogladE. GoyalA. RekhaM.M. SharmaG.C. JayabalanK. Tumor-educated platelets in lung cancer.Clin. Chim. Acta202557312030710.1016/j.cca.2025.120307
     [Google Scholar]
  4. StavropoulosI. SarantopoulosA. LiverezasA. Does sympathetic nervous system modulate tumor progression? A narrative review of the literature.J. Drug Assess.20209110611610.1080/21556660.2020.1782414 32939316
     [Google Scholar]
  5. FaulknerS. JoblingP. MarchB. JiangC.C. HondermarckH. Tumor neurobiology and the war of nerves in cancer.Cancer Discov.20199670271010.1158/2159‑8290.CD‑18‑1398 30944117
     [Google Scholar]
  6. KamiyaA. HiyamaT. FujimuraA. YoshikawaS. Sympathetic and parasympathetic innervation in cancer: Therapeutic implications.Clin. Auton. Res.202131216517810.1007/s10286‑020‑00724‑y
     [Google Scholar]
  7. QuF. BroughS.C. MichnoW. Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis.Nat. Cell Biol.202325101506151910.1038/s41556‑023‑01241‑6 37783795
     [Google Scholar]
  8. GuptaP.B. FillmoreC.M. JiangG. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.Cell2011146463364410.1016/j.cell.2011.07.026 21854987
     [Google Scholar]
  9. RestainoA.C. WalzA. VermeerS.J. Functional neuronal circuits promote disease progression in cancer.Sci. Adv.2023919eade444310.1126/sciadv.ade4443 37163587
     [Google Scholar]
  10. HussainM.S. SharmaS. KumariA. Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: Pathogenesis and therapeutic potential.Epigenomics20241623-241453146410.1080/17501911.2024.2430170 39601046
     [Google Scholar]
  11. ZhangD. ParkD. ZhongY. Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer.Nat. Commun.2016711079810.1038/ncomms10798 26924072
     [Google Scholar]
  12. ZengQ. MichaelI.P. ZhangP. Synaptic proximity enables NMDAR signalling to promote brain metastasis.Nature2019573777552653110.1038/s41586‑019‑1576‑6 31534217
     [Google Scholar]
  13. GuptaG. HussainM.S. PantK. AliH. ThapaR. BhatA.A. Antibody-drug conjugates (ADCs): A novel therapy for triple-negative breast cancer (TNBC).Curr. Cancer Drug Targets202525210811210.2174/0115680096343056240828190900 39248064
     [Google Scholar]
  14. VenkataramaniV. TanevD.I. KunerT. WickW. WinklerF. Synaptic input to brain tumors: Clinical implications.Neuro-oncol.2021231233310.1093/neuonc/noaa158 32623467
     [Google Scholar]
  15. ZhuS. HanX. QiaoX. ChenS. The immune landscape and prognostic immune key genes potentially involved in modulating synaptic functions in prostate cancer.Front. Oncol.202010133010.3389/fonc.2020.01330 32923385
     [Google Scholar]
  16. MancinoM. AmetllerE. GascónP. AlmendroV. The neuronal influence on tumor progression.Biochim. Biophys. Acta201118162105118 21616127
     [Google Scholar]
  17. MeyerJ. YuK. Luna-FigueroaE. DeneenB. NoebelsJ. Glioblastoma disrupts cortical network activity at multiple spatial and temporal scales.Nat. Commun.2024151450310.1038/s41467‑024‑48757‑5 38802334
     [Google Scholar]
  18. MonjeM. BornigerJ.C. D’SilvaN.J. Roadmap for the emerging field of cancer neuroscience.Cell2020181221922210.1016/j.cell.2020.03.034 32302564
     [Google Scholar]
  19. YuK. LinC.C.J. HatcherA. PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis.Nature2020578779316617110.1038/s41586‑020‑1952‑2 31996845
     [Google Scholar]
  20. ZhangY. LinC. LiuZ. Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies.Cell Metab.2022341219992017.e1010.1016/j.cmet.2022.10.012 36395769
     [Google Scholar]
  21. VenkateshH.S. MorishitaW. GeraghtyA.C. Electrical and synaptic integration of glioma into neural circuits.Nature2019573777553954510.1038/s41586‑019‑1563‑y 31534222
     [Google Scholar]
  22. MalekanM. NezamabadiS.S. SamamiE. MohebalizadehM. SaghazadehA. RezaeiN. BDNF and its signaling in cancer.J. Cancer Res. Clin. Oncol.202314962621263610.1007/s00432‑022‑04365‑8 36173463
     [Google Scholar]
  23. SinghA. ChengD. SwaminathanJ. REST-dependent downregulation of von Hippel-Lindau tumor suppressor promotes autophagy in SHH-medulloblastoma.Sci. Rep.20241411359610.1038/s41598‑024‑63371‑7 38866867
     [Google Scholar]
  24. BatsakisJ.G. Nerves and neurotropic carcinomas.Ann. Otol. Rhinol. Laryngol.198594442642710.1177/000348948509400420 4026129
     [Google Scholar]
  25. LiebigC. AyalaG. WilksJ.A. BergerD.H. AlboD. Perineural invasion in cancer.Cancer2009115153379339110.1002/cncr.24396 19484787
     [Google Scholar]
  26. RodinA.E. LarsonD.L. RobertsD.K. Nature of the perineural space invaded by prostatic carcinoma.Cancer196720101772177910.1002/1097‑0142(196710)20:10<1772:AID‑CNCR2820201028>3.0.CO;2‑# 6058181
     [Google Scholar]
  27. AyalaG.E. DaiH. IttmannM. Growth and survival mechanisms associated with perineural invasion in prostate cancer.Cancer Res.200464176082609010.1158/0008‑5472.CAN‑04‑0838 15342391
     [Google Scholar]
  28. ReevesF. HovensC.M. HarewoodL. Does perineural invasion in a radical prostatectomy specimen predict biochemical recurrence in men with prostate cancer?Can. Urol. Assoc. J.201595-625210.5489/cuaj.2619 26029290
     [Google Scholar]
  29. OlarA. HeD. FlorentinD. DingY. WheelerT. AyalaG. Biological correlates of prostate cancer perineural invasion diameter.Hum. Pathol.20144571365136910.1016/j.humpath.2014.02.011 24768607
     [Google Scholar]
  30. DunX.P. ParkinsonD. Role of netrin-1 signaling in nerve regeneration.Int. J. Mol. Sci.201718349110.3390/ijms18030491 28245592
     [Google Scholar]
  31. Melgarejo da RosaM. Clara SampaioM. Virgínia Cavalcanti SantosR. Unveiling the pathogenesis of perineural invasion from the perspective of neuroactive molecules.Biochem. Pharmacol.202118811454710.1016/j.bcp.2021.114547 33838132
     [Google Scholar]
  32. AyalaG.E. WheelerT.M. ShineH.D. In vitro dorsal root ganglia and human prostate cell line interaction: Redefining perineural invasion in prostate cancer.Prostate200149321322310.1002/pros.1137 11746267
     [Google Scholar]
  33. DaiH. LiR. WheelerT. Enhanced survival in perineural invasion of pancreatic cancer: An in vitro approach.Hum. Pathol.200738229930710.1016/j.humpath.2006.08.002 17097719
     [Google Scholar]
  34. CoarfaC. FlorentinD. PutluriN. Influence of the neural microenvironment on prostate cancer.Prostate201878212813910.1002/pros.23454 29131367
     [Google Scholar]
  35. DunX.P. ParkinsonD. Classic axon guidance molecules control correct nerve bridge tissue formation and precise axon regeneration.Neural Regen. Res.20201516910.4103/1673‑5374.264441 31535634
     [Google Scholar]
  36. PolleuxF. SniderW. Initiating and growing an axon.Cold Spring Harb. Perspect. Biol.201024a00192510.1101/cshperspect.a001925 20452947
     [Google Scholar]
  37. MukherjeeA. HaP. WaiK.C. NaaraS. The role of ECM remodeling, EMT, and adhesion molecules in cancerous neural invasion: Changing perspectives.Adv. Biol.202269220003910.1002/adbi.202200039 35798312
     [Google Scholar]
  38. ScuteriA. MilosoM. FoudahD. OrcianiM. CavalettiG. TrediciG. Mesenchymal stem cells neuronal differentiation ability: A real perspective for nervous system repair?Curr. Stem Cell Res. Ther.201162829210.2174/157488811795495486 21190538
     [Google Scholar]
  39. ChroscinskiD. SampeyD. MaheraliN. Registered report: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.eLife201540436310.7554/eLife.04363 25714925
     [Google Scholar]
  40. HanahanD. MonjeM. Cancer hallmarks intersect with neuroscience in the tumor microenvironment.Cancer Cell202341357358010.1016/j.ccell.2023.02.012 36917953
     [Google Scholar]
  41. DescampsS. LebourhisX. DeleheddeM. BoillyB. HondermarckH. Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells.J. Biol. Chem.199827327166591666210.1074/jbc.273.27.16659 9642218
     [Google Scholar]
  42. NicoB. MangieriD. BenagianoV. CrivellatoE. RibattiD. Nerve growth factor as an angiogenic factor.Microvasc. Res.200875213514110.1016/j.mvr.2007.07.004 17764704
     [Google Scholar]
  43. Di DonatoM. CerneraG. MigliaccioA. CastoriaG. Nerve growth factor induces proliferation and aggressiveness in prostate cancer cells.Cancers201911678410.3390/cancers11060784 31174415
     [Google Scholar]
  44. YangB. RenQ. ZhangJ. ChenQ-X. HashimotoK. Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: Rethinking the brain-liver axis.Transl. Psychiatry201775112810.1038/tp.2017.95 28509900
     [Google Scholar]
  45. YangZ. HoD. LauC. Significance of the serum brain-derived neurotrophic factor and platelets in hepatocellular carcinoma.Oncol. Rep.20061661237124310.3892/or.16.6.1237 17089044
     [Google Scholar]
  46. SerafimV.Junior FernandesG.M.M. Oliveira-CucoloJ.G. PavarinoE.C. Goloni-BertolloE.M. Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer.Cytokine202013615527010.1016/j.cyto.2020.155270 32911446
     [Google Scholar]
  47. ZageP.E. GrahamT.C. ZengL. The selective Trk inhibitor AZ623 inhibits brain‐derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan.Cancer201111761321139110.1002/cncr.25674 20960503
     [Google Scholar]
  48. KampanN.C. XiangS.D. McNallyO.M. StephensA.N. QuinnM.A. PlebanskiM. Immunotherapeutic interleukin-6 or interleukin-6 receptor blockade in cancer: Challenges and opportunities.Curr. Med. Chem.201825364785480610.2174/0929867324666170712160621 28707587
     [Google Scholar]
  49. OmarN.A. KumarJ. TeohS.L. Neurotrophin-3 and neurotrophin-4: The unsung heroes that lies behind the meninges.Neuropeptides20229210222610.1016/j.npep.2022.102226 35030377
     [Google Scholar]
  50. KeefeK. SheikhI. SmithG. Targeting neurotrophins to specific populations of neurons: NGF, BDNF, and NT-3 and their relevance for treatment of spinal cord injury.Int. J. Mol. Sci.201718354810.3390/ijms18030548 28273811
     [Google Scholar]
  51. GarridoM.P. TorresI. VegaM. RomeroC. Angiogenesis in gynecological cancers: Role of neurotrophins.Front. Oncol.2019991310.3389/fonc.2019.00913 31608227
     [Google Scholar]
  52. VanheckeE. AdriaenssensE. VerbekeS. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.Clin. Cancer Res.20111771741175210.1158/1078‑0432.CCR‑10‑1890 21350004
     [Google Scholar]
  53. MarchettiD. McCutcheonI.E. RossM.J. NicolsonG.L. Inverse expression of neurotrophins and neurotrophin receptors at the invasion front of human-melanoma brain metastases.Int. J. Oncol.199571879410.3892/ijo.7.1.87 21552811
     [Google Scholar]
  54. SeoaneJ. GomisR.R. TGF-β family signaling in tumor suppression and cancer progression.Cold Spring Harb. Perspect. Biol.2017912a02227710.1101/cshperspect.a022277 28246180
     [Google Scholar]
  55. LebrunJ.J. The dual role of TGFB in human cancer: From tumor suppression to cancer metastasis.ISRN Mol. Biol.2012381428 27340590
     [Google Scholar]
  56. KandasamyM. LehnerB. KrausS. TGF‐beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons.J. Cell. Mol. Med.20141871444145910.1111/jcmm.12298 24779367
     [Google Scholar]
  57. ConnollyE.C. FreimuthJ. AkhurstR.J. Complexities of TGF-β targeted cancer therapy.Int. J. Biol. Sci.20128796497810.7150/ijbs.4564 22811618
     [Google Scholar]
  58. XieY. SuN. YangJ. FGF/FGFR signaling in health and disease.Signal Transduct. Target. Ther.20205118110.1038/s41392‑020‑00222‑7 32879300
     [Google Scholar]
  59. KrookM.A. ReeserJ.W. ErnstG. Fibroblast growth factor receptors in cancer: Genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance.Br. J. Cancer2021124588089210.1038/s41416‑020‑01157‑0 33268819
     [Google Scholar]
  60. KatohM. LoriotY. BrandiG. TavolariS. WainbergZ.A. KatohM. FGFR-targeted therapeutics: Clinical activity, mechanisms of resistance and new directions.Nat. Rev. Clin. Oncol.202421431232910.1038/s41571‑024‑00869‑z 38424198
     [Google Scholar]
  61. LiuG. ChenT. DingZ. WangY. WeiY. WeiX. Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment.Cell Prolif.20215441300910.1111/cpr.13009 33655556
     [Google Scholar]
  62. LengrandJ. PastushenkoI. VanuytvenS. Pharmacological targeting of netrin-1 inhibits EMT in cancer.Nature2023620797340240810.1038/s41586‑023‑06372‑2 37532929
     [Google Scholar]
  63. FitamantJ. GuenebeaudC. CoissieuxM.M. Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer.Proc. Natl. Acad. Sci. USA2008105124850485510.1073/pnas.0709810105 18353983
     [Google Scholar]
  64. KandouzM. The Eph/Ephrin family in cancer metastasis: Communication at the service of invasion.Cancer Metastasis Rev.2012311-235337310.1007/s10555‑012‑9352‑1 22549394
     [Google Scholar]
  65. NeufeldG. MumblatY. SmolkinT. The role of the semaphorins in cancer.Cell Adhes. Migr.201610665267410.1080/19336918.2016.1197478 27533782
     [Google Scholar]
  66. MagnonC. HallS.J. LinJ. Autonomic nerve development contributes to prostate cancer progression.Science20133416142123636110.1126/science.1236361 23846904
     [Google Scholar]
  67. KapposE.A. EngelsP.E. TrempM. Denervation leads to volume regression in breast cancer.J. Plast. Reconstr. Aesthet. Surg.201871683383910.1016/j.bjps.2018.03.012 29653898
     [Google Scholar]
  68. HuangD. SuS. CuiX. Nerve fibers in breast cancer tissues indicate aggressive tumor progression.Medicine2014932717210.1097/MD.0000000000000172 25501061
     [Google Scholar]
  69. ZhaoC.M. HayakawaY. KodamaY. Denervation suppresses gastric tumorigenesis.Sci. Transl. Med.20146250250ra11510.1126/scitranslmed.3009569 25143365
     [Google Scholar]
  70. RoweC.W. DillT. GriffinN. Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion.Sci. Rep.2020101153910.1038/s41598‑020‑58425‑5 32001748
     [Google Scholar]
  71. DottoriniM.E. AssiA. SironiM. SangalliG. SpreaficoG. ColomboL. Multivariate analysis of patients with medullary thyroid carcinoma: Prognostic significance and impact on treatment of clinical and pathologic variables.Cancer19967781556156510.1002/(SICI)1097‑0142(19960415)77:8<1556:AID‑CNCR20>3.0.CO;2‑Y 8608543
     [Google Scholar]
  72. KelleyM.J. SniderR.H. BeckerK.L. JohnsonB.E. Small cell lung carcinoma cell lines express mRNA for calcitonin and alpha- and beta-calcitonin gene related peptides.Cancer Lett.1994811192510.1016/0304‑3835(94)90159‑7 8019984
     [Google Scholar]
  73. Kim-FuchsC. LeC.P. PimentelM.A. Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment.Brain Behav. Immun.201440404710.1016/j.bbi.2014.02.019 24650449
     [Google Scholar]
  74. YaoG.Y. ZhouJ.L. LaiM.D. ChenX.Q. ChenP.H. Neuroendocrine markers in adenocarcinomas: An investigation of 356 cases.World J. Gastroenterol.20039485886110.3748/wjg.v9.i4.858 12679948
     [Google Scholar]
  75. MarkinP.A. BritoA. MoskalevaN. LartsovaE.V. ShpotY.V. LernerY.V. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.Metabolomics20201677410.1007/s11306‑020‑01694‑y
     [Google Scholar]
  76. SperaG. FrescoR. FungH. Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: A retrospective analysis of the ROSE/TRIO-012 study.Ann. Oncol.20172881836184110.1093/annonc/mdx264 28520849
     [Google Scholar]
  77. MusselmanR.P. BennettS. LiW. MamdaniM. GomesT. van WalravenC. Association between perioperative beta blocker use and cancer survival following surgical resection.Eur. J. Surg. Oncol.20184481164116910.1016/j.ejso.2018.05.012
     [Google Scholar]
  78. GrytliH.H. FagerlandM.W. FossåS.D. TaskénK.A. Association between use of β-blockers and prostate cancer-specific survival: A cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.Eur. Urol.201465363564110.1016/j.eururo.2013.01.007 23351721
     [Google Scholar]
  79. MuñozM. CrespoJ.C. CrespoJ.P. CoveñasR. Neurokinin-1 receptor antagonist aprepitant and radiotherapy, a successful combination therapy in a patient with lung cancer: A case report.Mol. Clin. Oncol.20191115054 31289677
     [Google Scholar]
  80. VenkateshH.S. TamL.T. WooP.J. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.Nature2017549767353353710.1038/nature24014 28959975
     [Google Scholar]
  81. VenkateshH.S. JohungT.B. CarettiV. Neuronal activity promotes glioma growth through neuroligin-3 secretion.Cell2015161480381610.1016/j.cell.2015.04.012 25913192
     [Google Scholar]
  82. XingG. GanG. ChenD. Drosophila neuroligin3 regulates neuromuscular junction development and synaptic differentiation.J. Biol. Chem.201428946318673187710.1074/jbc.M114.574897 25228693
     [Google Scholar]
  83. RenzB.W. TanakaT. SunagawaM. Cholinergic signaling via muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and cancer stemness.Cancer Discov.20188111458147310.1158/2159‑8290.CD‑18‑0046 30185628
     [Google Scholar]
  84. HuangS. HanS. ZhangJ. ZhongZ. WangJ. Semaphorin 4C is upregulated in epithelial ovarian cancer.Oncol. Lett.20201943333333810.3892/ol.2020.11444 32256827
     [Google Scholar]
  85. ZahalkaA.H. Arnal-EstapéA. MaryanovichM. Adrenergic nerves activate an angio-metabolic switch in prostate cancer.Science2017358636132132610.1126/science.aah5072 29051371
     [Google Scholar]
  86. SalomanJ.L. AlbersK.M. LiD. Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer.Proc. Natl. Acad. Sci. USA2016113113078308310.1073/pnas.1512603113 26929329
     [Google Scholar]
  87. RenzB.W. TakahashiR. TanakaT. β2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer.Cancer Cell20183317590.e710.1016/j.ccell.2017.11.007 29249692
     [Google Scholar]
  88. PetersonS.C. EberlM. VagnozziA.N. Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches.Cell Stem Cell201516440041210.1016/j.stem.2015.02.006 25842978
     [Google Scholar]
  89. IacovelliL. ArcellaA. BattagliaG. Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas.J. Neurosci.200626328388839710.1523/JNEUROSCI.2285‑06.2006 16899734
     [Google Scholar]
  90. HayakawaY. SakitaniK. KonishiM. Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling.Cancer Cell2017311213410.1016/j.ccell.2016.11.005 27989802
     [Google Scholar]
  91. CeyhanG.O. GieseN.A. ErkanM. The neurotrophic factor artemin promotes pancreatic cancer invasion.Ann. Surg.2006244227428110.1097/01.sla.0000217642.68697.55 16858191
     [Google Scholar]
  92. LawnS. KrishnaN. PisklakovaA. Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.J. Biol. Chem.201529063814382410.1074/jbc.M114.599373 25538243
     [Google Scholar]
  93. HeS. ChenC.H. ChernichenkoN. GFRα1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling.Proc. Natl. Acad. Sci. USA201411119E2008E201710.1073/pnas.1402944111 24778213
     [Google Scholar]
  94. PanY. HysingerJ.D. BarronT. NF1 mutation drives neuronal activity-dependent initiation of optic glioma.Nature2021594786227728210.1038/s41586‑021‑03580‑6 34040258
     [Google Scholar]
  95. SenaldiG. VarnumB.C. SarmientoU. Novel neurotrophin-1/B cell-stimulating factor-3: A cytokine of the IL-6 family.Proc. Natl. Acad. Sci. USA19999620114581146310.1073/pnas.96.20.11458 10500198
     [Google Scholar]
  96. PearseR.N. SwendemanS.L. LiY. RafiiD. HempsteadB.L. A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival.Blood2005105114429443610.1182/blood‑2004‑08‑3096 15657181
     [Google Scholar]
  97. ChuY.H. Dias-SantagataD. FarahaniA.A. BoyrazB. FaquinW.C. NoséV. Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC). Modern pathology: An official journal of the United States and Canadian Academy of Pathology.Inc20203321862197
     [Google Scholar]
  98. FaragoAF TaylorMS DoebeleRC ZhuVW KummarS SpiraAI Clinicopathologic features of non-small-cell lung cancer harboring an NTRK gene fusion.JCO Precis Oncol2018PO.18.00037.10.1200/PO.18.00037
     [Google Scholar]
  99. VenkataramaniV. TanevD.I. StrahleC. Glutamatergic synaptic input to glioma cells drives brain tumour progression.Nature2019573777553253810.1038/s41586‑019‑1564‑x 31534219
     [Google Scholar]
  100. BabateenO. JinZ. BhandageA. Etomidate, propofol and diazepam potentiate GABA-evoked GABAA currents in a cell line derived from human glioblastoma.Eur. J. Pharmacol.201574810110710.1016/j.ejphar.2014.12.001 25510230
     [Google Scholar]
  101. LabrakakisC. PattS. HartmannJ. KettenmannH. Functional GABA A receptors on human glioma cells.Eur. J. Neurosci.199810123123810.1046/j.1460‑9568.1998.00036.x 9753131
     [Google Scholar]
  102. CampbellS.L. RobelS. CuddapahV.A. GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy.Glia2015631233610.1002/glia.22730 25066727
     [Google Scholar]
  103. NemanJ. TerminiJ. WilczynskiS. Human breast cancer metastases to the brain display GABAergic properties in the neural niche.Proc. Natl. Acad. Sci. USA2014111398498910.1073/pnas.1322098111 24395782
     [Google Scholar]
  104. DoumaS. van LaarT. ZevenhovenJ. MeuwissenR. van GarderenE. PeeperD.S. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.Nature200443070031034103910.1038/nature02765 15329723
     [Google Scholar]
  105. SloanE.K. PricemanS.J. CoxB.F. The sympathetic nervous system induces a metastatic switch in primary breast cancer.Cancer Res.201070187042705210.1158/0008‑5472.CAN‑10‑0522 20823155
     [Google Scholar]
  106. OsswaldM JungE SahmF Brain tumour cells interconnect to a functional and resistant network.Nature20155287580939810.1038/nature1607126536111
     [Google Scholar]
  107. ZhuZ. FriessH. diMolaF.F. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer.J. Clin. Oncol.19991782419242810.1200/JCO.1999.17.8.2419 10561305
     [Google Scholar]
  108. AnandU. OttoW.R. CasulaM.A. The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neurons.Neurosci. Lett.20063991-2515610.1016/j.neulet.2006.01.046 16481104
     [Google Scholar]
  109. BhatK. SakiM. ChengF. Dopamine receptor antagonists, radiation, and cholesterol biosynthesis in mouse models of glioblastoma.J. Natl. Cancer Inst.202111381094110410.1093/jnci/djab018 33556960
     [Google Scholar]
  110. AuC.W.H. SiuM.K.Y. LiaoX. Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome.Cancer Lett.2009281215116110.1016/j.canlet.2009.02.025 19307055
     [Google Scholar]
  111. BanhR.S. BiancurD.E. YamamotoK. Neurons release serine to support mRNA translation in pancreatic cancer.Cell2020183512021218.e2510.1016/j.cell.2020.10.016 33142117
     [Google Scholar]
  112. De GiorgiV. GrazziniM. BenemeiS. Propranolol for off-label treatment of patients with melanoma.JAMA Oncol.20184217290810.1001/jamaoncol.2017.2908 28973254
     [Google Scholar]
  113. KokolusK.M. ZhangY. SivikJ.M. Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice.OncoImmunology201873140520510.1080/2162402X.2017.1405205 29399407
     [Google Scholar]
  114. ChenM. QiaoG. HylanderB.L. Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation.Nat. Commun.2020111182110.1038/s41467‑020‑15676‑0 32286326
     [Google Scholar]
  115. DaherC. VimeuxL. StoevaR. Blockade of β-adrenergic receptors improves CD8+ T-cell priming and cancer vaccine efficacy.Cancer Immunol. Res.20197111849186310.1158/2326‑6066.CIR‑18‑0833 31527069
     [Google Scholar]
  116. PeranzoniE. LemoineJ. VimeuxL. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of] anti-PD-1 treatment.Proc. Natl. Acad. Sci. USA201811517E4041E405010.1073/pnas.1720948115 29632196
     [Google Scholar]
  117. LeclercM. VoilinE. GrosG. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1.Nat. Commun.2019101334510.1038/s41467‑019‑11280‑z 31350404
     [Google Scholar]
  118. ShurinG.V. KruglovO. DingF. Melanoma-induced reprogramming of schwann cell signaling aids tumor growth.Cancer Res.201979102736274710.1158/0008‑5472.CAN‑18‑3872 30914431
     [Google Scholar]
  119. YangM.W. TaoL.Y. JiangY.S. Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma.Cancer Res.202080101991200310.1158/0008‑5472.CAN‑19‑2689 32098780
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128402718250806151308
Loading
Exploring the Neurobiological Mechanisms of Cancer Growth
Curr. Pharm. Des. 32, 1002 (2026); https://doi.org/10.2174/0113816128402718250806151308
/content/journals/cpd/10.2174/0113816128402718250806151308
/content/journals/cpd/10.2174/0113816128402718250806151308
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Cancer metastasis; metastasis; neuronal plasticity; neurotrophic factors; synaptic transmission; tumor microenvironment

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test